The 1.03 million yen ceiling and earnings inequality among married women in Japan

In this paper, we examine the impact of the `1.03 million yen ceiling,' a means-tested transfer scheme for secondary earners in Japan, on earnings inequality of married women. We find that the decline in earnings inequality among married women between 1993 and 2003 is attributable to the increase in the number of wives with low earnings and the decrease in the number of wives with zero earnings.Coefficient of variation, 1.03 million yen ceiling, Japan

Does Social Security Induce Withdrawal of the Old from the Labor Force and Create Jobs for the Young?: The Case of Japan

This paper examines whether social security programs induce a withdrawal of the elderly from the labor force and create jobs for the young in Japan. The key messages are summarized as follows. First, our historical overview suggests that young unemployment issues have not motivated social security reforms and that changes in provisions are not endogenous. Second, employment of the young tends to be positively, not negatively, associated with the LFP of the old. Third, an increase in the inducement to retire significantly discourages the old from staying in the labor force, but does not create jobs for the young.

Social Security Reforms and Labor Force Participation of the Elderly in Japan

We examine how social security programs have affected the labor force participation (LFP) of the elderly over the past forty years in Japan. Using publicly available data, we construct forwardlooking incentive measures for inducing retirement, to ascertain the actual changes in the generosity of the programs and to explore the impact of the reforms on the labor supply of the elderly. Our regression analysis shows that the LFP of the elderly is significantly sensitive to the measures, and our counter-historical simulations show that since 1985, social security reforms have significantly encouraged the elderly to remain longer in the labor force.social security program, social security wealth, labor force participation of the elderly

Endometrial Cancer Arising in Adenomyosis That Could Not Be Diagnosed by Endometrial Biopsy: A Case Report

Uterine adenomyosis is an estrogen-dependent tumor and one of the most common benign diseases in sexually mature women. The frequency of endometrial cancer associated with adenomyosis has been reported to be 18%–66%. On the other hand, endometrial cancer arising in adenomyosis (EC-AIA) is extremely rare. EC-AIA is now considered a different entity from and has a worse prognosis than endometrial cancer with adenomyosis (EC-A). In the present study, we report a case of endometrial cancer with adenomyosis in which endometrial biopsy failed to provide a definitive diagnosis. A 63-year-old female patient presented with endometrial thickening. Endometrial cytology was positive, and magnetic resonance imaging (MRI) showed small lesions suggestive of endometrial cancer with shallow invasion and adenomyosis. However, an endometrial biopsy showed only metaplasia, and careful follow-up was initiated. Subsequent endometrial cytology showed enlarged and round nuclei, uniform chromatin distribution, no thickening of nuclear margins, and abundant cytoplasm appearing in a sheet-like arrangement, suggesting atypical cells of endometrial glands with metaplasia. Three suspicious positive results and one positive result were observed, but repeated biopsies did not lead to the diagnosis of malignancy. The patient underwent diagnostic hysterectomy 19 months after the initial visit. The postoperative histopathological diagnosis was stage IA endometrial cancer (endometrioid carcinoma G1). This case of endometrial cancer associated with adenomyosis was difficult to diagnose. Our findings demonstrate that EC-AIA should be considered even if no lesions were detected by endometrial biopsy

Recurrent colon perforation after discontinuation of bevacizumab for ovarian cancer

Bevacizumab (Bev) is an antiangiogenic drug used to treat various malignances, including ovarian cancer (OC). Bev is generally well-tolerated; however, it has a characteristic toxicity profile. In particular, gastrointestinal perforation (GIP) is a rare but serious side effect that can be lethal. A 55-year-old woman with recurrent OC had an episode of GIP during third-line chemotherapy comprising Bev and topotecan (TPT). Bev was discontinued while TPT was continued as monotherapy. Three months after discontinuation of Bev, the patient presented with left lower abdominal pain and was diagnosed with a second GIP. She had emergent surgery. One year later, she is still alive and healthy, and is continuing TPT. This is the first report of recurrent GIP after discontinuation of Bev. Our case suggests that physicians should be aware of GIP even after the discontinuation of Bev. Keywords: Bevacizumab, Gastrointestinal perforation, Recurrent ovarian cancer, Salvage chemotherap